Loading...
OTCM
EMITF
Market cap21mUSD
Sep 28, Last price  
0.05USD
Name

Elbit Imaging Ltd

Chart & performance

D1W1MN
OTCM:EMITF chart
P/E
—
P/S
0.06
EPS
—
Vol. 1Y
—
Shs. 5Y
7.64%
Rev. 5Y
-30.45%
Div Yld LY
—
Div Yld TTM
—
Revenues
38m
1,665,606,0003,507,466,0001,098,317,000600,588,000582,984,000475,155,00030,379,0001,965,000398,578,000200,078,000261,858,000782,829,00000000328,000037,512,740
Net income
-5m
L-1.19%
559,483,000539,749,000-103,170,000-530,942,00061,998,000-264,919,000-315,746,000-1,155,645,0001,008,999,000-186,150,000-194,830,000-338,034,000-517,833,000-107,497,000229,851,000-20,498,000-2,355,000-18,143,000-5,327,000-5,263,703
CFO
-7m
L+1,113.93%
-521,802,3750220,656,000-754,331,000-334,587,000-240,889,000-148,624,000-16,873,000281,135,000191,353,000158,755,000433,812,000-20,293,000-14,803,000-15,649,000-3,378,000-3,437,000-2,953,000-582,000-7,065,049
Dividend
Jun 29, 20230.03932263 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Elbit Imaging Ltd. is an Israeli-based company, with operations extending internationally, that specializes in the creation, production, and distribution of therapeutic medical systems designed for non-invasive procedures on the human body. Their offerings include advanced medical devices that leverage ultrasound beam technology and magnetic resonance imaging for treatment purposes. Furthermore, the company develops medical solutions utilizing stem cells, primarily derived from umbilical cord blood. These stem cell products are intended for bone marrow transplantation in patients suffering from conditions such as leukemia, lymph node cancer, various non-malignant blood disorders, and inherited metabolic diseases. Beyond its medical ventures, Elbit Imaging also holds real estate interests, specifically in the sale of land parcels and villas within India. The company, founded in 1996, changed its name from Elbit Medical Imaging Ltd. to its current designation in November 2007, and it is headquartered in Petach Tikva, Israel.

Key people

Chief Financial Officer · since 2016
Zvi Maayan
Vice President, General Counsel · since 2008
Oren Kolton
India Country Director · since 2010
Chairman of the Board
Moshe Lion
Director · since 2006
Shmuel Peretz
Director · since 2006
Director · since 2003
Hanoch Ehrlich
External Director · since 2019
Shlomo Nissim
External Director · since 2019
External Independent Director · since 2008
Zvi Tropp
External and Independent Director · since 2004
IPO date
Nov 01, 1996
Employees
3
Domiciled in
IL
Incorporated in
IL
Headquarters & legal address
5 KINNERET STREET
BNEI BRAK, TA 51261
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT